Our clinical research department has accompanied more than 25 human clinical studies investigating very innovative nutrition and medical device products, conducted either for marketing or regulatory purposes. a&r offers a newly developed quality management approach, which provides exactly those services that are required to deliver high-quality data by reflecting the specific needs and requirements (budgets!) of clients and products.
In one health claim application process, the EFSA panel confirmed that the clinical studies conducted by a&r have shown the claimed effect. Thus, we know how to run studies accepted by EFSA.
Thanks to very precise planning and perfect execution by our clinical operations team, a&r was able to include more than 700 subjects in a cold-and-cough study within 4 months, and this only in the Berlin area. By the way – completely within the previously agreed budget!
In 2019, we were able to expand our expertise in weight management, prediabetics, and infant nutrition. Another growth & tolerance study aiming for more than 300 newborns investigating a new infant formula will be closed in recruitment soon due to a unique collaboration with only 12 (!) efficiently operating clinical trial centers and partners in 3 European countries.
When requested by our clients, we also publish the results of clinical studies conducted by our CRO. Recently, we published the results of 2 clinical studies, one being on effects of aged garlic extract on arterial elasticity using EndoPATTM technology and the other one on the safety and tolerability of cellobiose in healthy subjects. For full information on these publications, click here. Furthermore, we have recently successfully completed one FDA regulatory study, and another one is ongoing.